StockData
Protara Therapeutics, Inc. logo

Protara Therapeutics, Inc. (TARA) stock

TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$2.34+0.02 (+0.86%)

Close on Nov 18, 2026Market cap $138.28MP/E –Yield –

Protara Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Protara Therapeutics's price to sales ratio was 67.3× on Apr 30, 2015.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Apr 30, 201567.3×–

More Protara Therapeutics figures

See a number that looks wrong?